Guizhou Yibai Pharmaceutical Co (SHSE:600594) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600594 Guizhou Yibai Pharmaceutical Co Ltd SHSE:600594
53 GF Score
Price ¥3.30
GF Value ¥3.17
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Guizhou Yibai Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:600594 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Yibai Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guizhou Yibai Pharmaceutical Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Yibai Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Guizhou Yibai Pharmaceutical Co's Short Interest falls into.


SHSE:600594
53GF Score
Guizhou Yibai Pharmaceutical Co Ltd SHSE:600594
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guizhou Yibai Pharmaceutical Co (SHSE:600594) Overvalued in 2026?

Based on GuruFocus' analysis, Guizhou Yibai Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥3.30 is trading 4.1% above its estimated GF Value™ of ¥3.17. GuruFocus considers Guizhou Yibai Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600594:

  • Short Interest:
  • GF Value™: ¥3.17 vs. price of ¥3.30 (4.1% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guizhou Yibai Pharmaceutical Co Business Description

Address No. 220-1 Baiyun Avenue, Guiyang, Guizhou, CHN, 550008
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
53GF Score

Get the complete analysis for SHSE:600594

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.30
Price
¥3.17
GF Value